Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2
Clinical trial NCT01763918 · COMPLETED
Trial details
- NCT number
- NCT01763918
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-07
- Primary completion
- 2013-11-27
- Enrollment
- 331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.